There are 2789 resources available
LBA30 - Single-dose carboplatin followed by involved-node radiotherapy as curative treatment for seminoma stage IIA/B: Efficacy results from the international multicenter phase II trial SAKK 01/10
Presenter: Alexandros Papachristofilou
Session: Proffered Paper session - Genitourinary tumours, non-prostate 2
Resources:
Abstract
Slides
Webcast
340O - Radiotherapy is associated with deletion signatures that contribute to poor survival outcomes in cancer patients
Presenter: Emre Kocakavuk
Session: Proffered Paper session - CNS tumours
Resources:
Abstract
Slides
Webcast
341O - A phase 0 ‘Trigger’ trial of CDK4/6 plus ERK1/2 inhibitors in recurrent glioblastoma
Presenter: Nader Sanai
Session: Proffered Paper session - CNS tumours
Resources:
Abstract
Slides
Webcast
342O - Intracranial administration of CTLA-4 and PD-1 immune checkpoint blocking monoclonal antibodies in recurrent glioblastoma (rGB): A multi-cohort adaptive phase I clinical trial
Presenter: Bart Neyns
Session: Proffered Paper session - CNS tumours
Resources:
Abstract
Slides
Webcast
1758O - Neoadjuvant pembrolizumab in localized/locally advanced solid tumors with mismatch repair deficiency
Presenter: Kaysia Ludford
Session: Proffered Paper session - Translational research
Resources:
Abstract
Slides
Webcast
LBA16 - KEYNOTE-355: Final results from a randomized, double-blind phase III study of first-line pembrolizumab + chemotherapy vs placebo + chemotherapy for metastatic TNBC
Presenter: Hope Rugo
Session: Proffered Paper session - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
LBA17_PR - Overall survival (OS) results from the phase III MONALEESA-2 (ML-2) trial of postmenopausal patients (pts) with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2−) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib (RIB)
Presenter: Gabriel Hortobagyi
Session: Proffered Paper session - Breast cancer, metastatic
Resources:
Abstract
Slides
Webcast
653O - Pembrolizumab (pembro) vs placebo as adjuvant therapy for patients (pts) with renal cell carcinoma (RCC): Patient-reported outcomes (PRO) in KEYNOTE-564
Presenter: Toni Choueiri
Session: Proffered Paper session - Genitourinary tumours, non-prostate 2
Resources:
Abstract
Slides
Webcast
LBA56 - Perioperative or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer: Results of the NEONAX trial, a randomized phase II AIO study
Presenter: Thomas Seufferlein
Session: Proffered Paper session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast
LBA57 - Unicancer PRODIGE 24/CCTG PA6 trial: Updated results of a multicenter international randomized phase III trial of adjuvant mFOLFIRINOX (mFFX) versus gemcitabine (gem) in patients (pts) with resected pancreatic ductal adenocarcinomas (PDAC)
Presenter: Thierry Conroy
Session: Proffered Paper session - Gastrointestinal tumours, non-colorectal
Resources:
Abstract
Slides
Webcast